Works by Hayato, Seiichi

Results: 17

Dose-response relationships of rabeprazole 5, 10, 20, and 40 mg once daily on suppression of gastric acid secretion through the night in healthy Japanese individuals with different CYP2C19 genotypes.

Published in:

European Journal of Clinical Pharmacology, 2012, v. 68, n. 5, p. 579, doi. 10.1007/s00228-011-1164-7

By:

Hayato, Seiichi;
Hasegawa, Setsuo;
Hojo, Seiichiro;
Okawa, Hiroki;
Abe, Hiroaki;
Sugisaki, Nobuyuki;
Munesue, Masahiro;
Horai, Yukio;
Ohnishi, Akihiro

Publication type:

Article

Phase 2 study of lenvatinib in patients with advanced hepatocellular carcinoma.

Published in:

2017

By:

Ikeda, Kenji;
Kudo, Masatoshi;
Kawazoe, Seiji;
Osaki, Yukio;
Ikeda, Masafumi;
Okusaka, Takuji;
Tamai, Toshiyuki;
Suzuki, Takuya;
Hisai, Takashi;
Hayato, Seiichi;
Okita, Kiwamu;
Kumada, Hiromitsu

Publication type:

journal article

Pharmacokinetic and Exposure–Response Modeling Support Body Surface Area‐Based Dosing of Farletuzumab Ecteribulin in Japanese Patients with Solid Tumors.

Published in:

Journal of Clinical Pharmacology, 2025, v. 65, n. 6, p. 751, doi. 10.1002/jcph.6187

By:

Hayato, Seiichi;
Hamuro, Lora;
Shimizu, Toshio;
Yonemori, Kan;
Nishio, Shin;
Yunokawa, Mayu;
Yoshida, Tatsuya;
Nishio, Makoto;
Matsumoto, Koji;
Takehara, Kazuhiro;
Hasegawa, Kosei;
Kozuki, Toshiyuki;
Hirashima, Yasuyuki;
Kato, Hidenori;
Miura, Takuma;
Nomoto, Maiko;
Zhao, Yue;
Zhu, Li;
Yasuda, Sanae

Publication type:

Article

Population pharmacokinetics and exposure–response analyses of safety (ARIA‐E and isolated ARIA‐H) of lecanemab in subjects with early Alzheimer's disease.

Published in:

CPT: Pharmacometrics & Systems Pharmacology, 2024, v. 13, n. 12, p. 2111, doi. 10.1002/psp4.13224

By:

Majid, Oneeb;
Cao, Youfang;
Willis, Brian A.;
Hayato, Seiichi;
Takenaka, Osamu;
Lalovic, Bojan;
Sreerama Reddy, Sree Harsha;
Penner, Natasha;
Reyderman, Larisa;
Yasuda, Sanae;
Hussein, Ziad

Publication type:

Article

Population pharmacokinetic‐pharmacodynamic modeling of serum biomarkers as predictors of tumor dynamics following lenvatinib treatment in patients with radioiodine‐refractory differentiated thyroid cancer (RR‐DTC).

Published in:

CPT: Pharmacometrics & Systems Pharmacology, 2024, v. 13, n. 6, p. 954, doi. 10.1002/psp4.13130

By:

Majid, Oneeb;
Hayato, Seiichi;
Sreerama Reddy, Sree Harsha;
Lalovic, Bojan;
Hihara, Taro;
Hoshi, Taisuke;
Funahashi, Yasuhiro;
Aluri, Jagadeesh;
Takenaka, Osamu;
Yasuda, Sanae;
Hussein, Ziad

Publication type:

Article

Population pharmacokinetic‐pharmacodynamic analyses of amyloid positron emission tomography and plasma biomarkers for lecanemab in subjects with early Alzheimer's disease.

Published in:

CPT: Pharmacometrics & Systems Pharmacology, 2022, v. 11, n. 12, p. 1578, doi. 10.1002/psp4.12862

By:

Hayato, Seiichi;
Takenaka, Osamu;
Sreerama Reddy, Sree Harsha;
Landry, Ishani;
Reyderman, Larisa;
Koyama, Akihiko;
Swanson, Chad;
Yasuda, Sanae;
Hussein, Ziad

Publication type:

Article

Exposure‐response modeling to describe the change in brain amyloid following lecanemab administration in patients with early Alzheimer's disease.

Published in:

Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 21, p. 1, doi. 10.1002/alz.080393

By:

Willis, Brian A.;
Hussein, Ziad;
Hayato, Seiichi;
Takenaka, Osamu;
Penner, Natasha;
Yasuda, Sanae;
Reyderman, Larisa

Publication type:

Article

Subcutaneous Dose Selection of Lecanemab for Treatment of Subjects with Early Alzheimer's Disease (EAD).

Published in:

Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 10, p. 1, doi. 10.1002/alz.069429

By:

Hayato, Seiichi;
Rawal, Sumit;
Takenaka, Osamu;
Landry, Ishani;
Boyd, Peter;
Aluri, Jagadeesh;
Willis, Brian A;
Swanson, Chad J;
Yasuda, Sanae;
Hussein, Ziad;
Reyderman, Larisa

Publication type:

Article

Modeled Impact of APOE4 Genotype on ARIA‐E Incidence in Patients Treated With Lecanemab.

Published in:

Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 10, p. 1, doi. 10.1002/alz.069402

By:

Reyderman, Larisa;
Hayato, Seiichi;
Reddy, Harsha;
Takenaka, Osamu;
Yasuda, Sanae;
Swanson, Chad J;
Willis, Brian A;
Hussein, Ziad

Publication type:

Article

P4‐657: POPULATION PHARMACOKINETIC/PHARMACODYNAMIC ANALYSES OF BAN2401 IN PATIENTS WITH EARLY ALZHEIMER'S DISEASE: CORRELATION OF BAN2401 EXPOSURE, PET STANDARD UPTAKE VALUE RATIO, AND COGNITIVE OUTCOMES.

Published in:

Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P1582, doi. 10.1016/j.jalz.2019.09.023

By:

Schuck, Edgar L.;
Reyderman, Larisa;
Hayato, Seiichi;
Takenaka, Osamu;
Swanson, Chad J.;
Lai, Robert YK.;
Hussein, Ziad;
Ferry, Jim

Publication type:

Article

Subgroup analysis of Japanese patients in a phase 3 study of lenvatinib in radioiodine-refractory differentiated thyroid cancer.

Published in:

Cancer Science, 2015, v. 106, n. 12, p. 1714, doi. 10.1111/cas.12826

By:

Kiyota, Naomi;
Schlumberger, Martin;
Muro, Kei;
Ando, Yuichi;
Takahashi, Shunji;
Kawai, Yasukazu;
Wirth, Lori;
Robinson, Bruce;
Sherman, Steven;
Suzuki, Takuya;
Fujino, Katsuki;
Gupta, Anubha;
Hayato, Seiichi;
Tahara, Makoto

Publication type:

Article

Application of model-informed drug development (MIDD) for dose selection in regulatory submissions for drug approval in Japan.

Published in:

Journal of Pharmacokinetics & Pharmacodynamics, 2025, v. 52, n. 1, p. 1, doi. 10.1007/s10928-024-09954-3

By:

Sasaki, Tomohiro;
Katsube, Takayuki;
Hayato, Seiichi;
Yamaguchi, Shingo;
Tanaka, Jun;
Yoshimatsu, Hiroki;
Nakanishi, Yushi;
Kitamura, Atsushi;
Watase, Hirotaka;
Suganami, Hideki;
Matsuoka, Nobushige;
Hasegawa, Chihiro

Publication type:

Article

Application of model-informed drug development (MIDD) for dose selection in regulatory submissions for drug approval in Japan.

Published in:

Journal of Pharmacokinetics & Pharmacodynamics, 2025, v. 52, n. 1, p. 1, doi. 10.1007/s10928-024-09954-3

By:

Sasaki, Tomohiro;
Katsube, Takayuki;
Hayato, Seiichi;
Yamaguchi, Shingo;
Tanaka, Jun;
Yoshimatsu, Hiroki;
Nakanishi, Yushi;
Kitamura, Atsushi;
Watase, Hirotaka;
Suganami, Hideki;
Matsuoka, Nobushige;
Hasegawa, Chihiro

Publication type:

Article

Exposure-response analysis and simulation of lenvatinib safety and efficacy in patients with radioiodine-refractory differentiated thyroid cancer.

Published in:

2018

By:

Hayato, Seiichi;
Shumaker, Robert;
Ferry, Jim;
Binder, Terri;
Dutcus, Corina E.;
Hussein, Ziad

Publication type:

journal article

Dose Finding of Lenvatinib in Subjects With Advanced Hepatocellular Carcinoma Based on Population Pharmacokinetic and Exposure-Response Analyses.

Published in:

Journal of Clinical Pharmacology, 2017, v. 57, n. 9, p. 1138, doi. 10.1002/jcph.917

By:

Tamai, Toshiyuki;
Hayato, Seiichi;
Hojo, Seiichiro;
Suzuki, Takuya;
Okusaka, Takuji;
Ikeda, Kenji;
Kumada, Hiromitsu

Publication type:

Article

Lenvatinib dose, efficacy, and safety in the treatment of multiple malignancies.

Published in:

Expert Review of Anticancer Therapy, 2022, v. 22, n. 4, p. 383, doi. 10.1080/14737140.2022.2039123

By:

Motzer, Robert J.;
Taylor, Matthew H.;
Evans, Thomas R. Jeffry;
Okusaka, Takuji;
Glen, Hilary;
Lubiniecki, Gregory M.;
Dutcus, Corina;
Smith, Alan D.;
Okpara, Chinyere E.;
Hussein, Ziad;
Hayato, Seiichi;
Tamai, Toshiyuki;
Makker, Vicky

Publication type:

Article

Safety and efficacy of lenvatinib by starting dose based on body weight in patients with unresectable hepatocellular carcinoma in REFLECT.

Published in:

2021

By:

Okusaka, Takuji;
Ikeda, Kenji;
Kudo, Masatoshi;
Finn, Richard;
Qin, Shukui;
Han, Kwang-Hyub;
Cheng, Ann-Lii;
Piscaglia, Fabio;
Kobayashi, Masahiro;
Sung, Max;
Chen, Minshan;
Wyrwicz, Lucjan;
Yoon, Jung-Hwan;
Ren, Zhenggang;
Mody, Kalgi;
Dutcus, Corina;
Tamai, Toshiyuki;
Ren, Min;
Hayato, Seiichi;
Kumada, Hiromitsu

Publication type:

journal article